A detailed history of Anfield Capital Management, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Anfield Capital Management, LLC holds 40 shares of DGX stock, worth $5,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$5,483
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$125.91 - $144.34 $5,036 - $5,773
40 New
40 $5,000
Q4 2021

Feb 03, 2022

BUY
$140.36 - $173.01 $27,229 - $33,563
194 Added 1077.78%
212 $37,000
Q3 2021

Nov 04, 2021

BUY
$132.95 - $158.0 $2,393 - $2,844
18 New
18 $3,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.